|
Contents
|
|
|
|
Malignant
Lymphomas |
|
|
|
|
Abdelsalam
M, Elthusseiny G, Akhtar S, Khafaga Y, Alt Shabana M, Alhusaini H, El Weshi
A, Rahal M, Maghfoor I.
Improved survival with combined chemo-radiotherapy in primary central
nervous system lymphoma.
Hematol Oncol Stem Cell Ther. 2010 Oct 10;3(3):128-34.
.JPG)
Abstract | .png)
Reprint |
.gif) Related
articles
|
|
|
Ferreri AJ, Verona C, Politi LS, Chiara A, Perna L, Villa E, Reni M.
Consolidation
radiotherapy in primary central nervous system lymphomas: impact on outcome
of different fields and doses in patients in complete remission after
upfront chemotherapy.
Int
J Radiat Oncol Biol Phys. 2011 May 1;80(1):169-75. Epub 2010 Jun 26.
Abstract |
Related articles
|
|
Lauren E. Abrey, Leah
Ben-Porat, Katherine S. Panageas, Joachim Yahalom,
Brian Berkey, Walter Curran, Christopher Schultz,
Steven Leibel, Diana Nelson, Minesh Mehta,
Lisa M. DeAngelis
Primary Central Nervous System Lymphoma: The
Memorial Sloan-Kettering Cancer Center Prognostic Model
Journal of Clinical Oncology, Vol 24, No 36 (December 20), 2006: pp. 5711-5715;
Epub November 20 2006
|
|
L.
E. Abrey,
D. A. Filippa, L. M. DeAngelis
Clinical
correlation of histologic and genetic features in primary CNS lymphoma (PCNSL)
39th ASCO Annual Meeting. Chicago, IL. May 31-June 3, 2003. Abstract No. 417
|
|
|
Kristina M. Braaten,
Rebecca A. Betensky, Laurence de Leval, Yoshifumi
Okada, Fred H. Hochberg, David N. Louis, Nancy
L. Harris and Tracy T. Batchelor
BCL-6 Expression Predicts Improved Survival in Patients with Primary
Central Nervous System Lymphoma
Clinical Cancer Research Vol. 9, 1063-1069, 1 March 2003
Abstract
|
.png) Full Text
|
Reprint
|
|
|
Cady FM, O'Neill BP, Law ME, Decker PA, Kurtz DM, Giannini C, Porter AB,
Kurtin PJ, Johnston PB, Dogan A, Remstein ED
Del(6)(q22)
and BCL6 rearrangements in primary CNS lymphoma are indicators of an
aggressive clinical course
J
Clin Oncol. 2008 Oct 10;26(29):4814-9. Epub 2008 Jul 21
Abstract
|
|
|
Haldorsen IS, Krossnes BK, Aarseth JH, Scheie D,
Johannesen TB, Mella O, Espeland A.
Increasing incidence and continued dismal outcome of primary central
nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year
national survey.
Cancer. 2007 Oct 15;110(8):1803-14
Abstract
|
|
|
Levy O, Deangelis LM, Filippa DA, Panageas KS,
Abrey LE
Bcl-6 predicts improved prognosis in primary central nervous system
lymphoma
Cancer. 2008 Jan 1;112(1):151-6.
Published Online: 12 Nov 2007
Abstract
|
|
Beela
S Mathew, Kathryn A Carson, Stuart A Grossman, Regional Cancer Centre,
Trivandrum, India; Johns Hopkins Hospital, Baltimore, MD
Initial
response to glucocorticoids: an important prognostic factor in patients
with primary CNS lymphoma (PCNSL)
38th
ASCO Annual Meeting. Orlando, FL. May 18-21, 2002. 300
|
|
|
Ney
DE, Reiner AS, Panageas KS, Brown HS, DeAngelis LM, Abrey LE.
Characteristics
and outcomes of elderly patients with primary central nervous system
lymphoma: the Memorial Sloan-Kettering Cancer Center experience.
Cancer. 2010 Oct
1;116(19):4605-12.
Abstract |
Related
articles
|
|
|
Norden
AD, Drappatz J, Wen PY, Claus EB.
Survival
among patients with primary central nervous system lymphoma, 1973-2004.
J
Neurooncol. 2011 Feb;101(3):487-93. Epub 2010 Jun 17.
Abstract |
Reprint |
Related articles
|
|
|
|
